Mononucleosis in Emergency Medicine Clinical Presentation

  • Author: Michael S Omori, MD; Chief Editor: Pamela L Dyne, MD   more...
 
Updated: May 23, 2012
 

History

  • Infectious mononucleosis may have a varied clinical presentation, but the symptoms usually consist of fever, pharyngitis, and lymphadenopathy.
  • The incubation period of infectious mononucleosis is 4-6 weeks. Patients usually do not recall a history of possible exposure.
  • Prodromal symptoms consisting of 1-2 weeks of fatigue, malaise, and myalgia are common.
    • Patients may present during the prodrome, which makes specific diagnosis difficult, or they may present with clinical infectious mononucleosis and admit a history of antecedent prodromal symptoms.
    • Abrupt onset of infectious mononucleosis symptoms with no prodrome may occur.
  • Low-grade fever usually is present and lasts 1-2 weeks, but it may persist for 4-5 weeks.
  • Pharyngitis is one of the cardinal symptoms of infectious mononucleosis, and it may be severe and/or exudative, particularly during the first week of symptoms, with gradual improvement thereafter.
  • Tonsillitis may be present.
  • Lymphadenopathy is almost universal, and it lasts for 1-2 weeks.
  • Posterior cervical nodes commonly are affected, but generalized adenopathy also may occur.
  • Patients often complain of headache.
  • A morbilliform or papular erythematous eruption of the upper extremities or trunk accompanies infectious mononucleosis in approximately 5% of cases.
  • A macular erythematous rash may occur in patients with infectious mononucleosis who are treated with ampicillin. This usually occurs after 5-9 days of antibiotic treatment, and typically this rash is tan or brownish in color. Since the color is quite different than the typical very red allergic-type rash, this should not be misinterpreted as a penicillin allergy. However, because the shape and distribution of the rash of infectious mononucleosis plus antibiotics are similar to an allergic-type rash, they are often confused by patients and clinicians.
  • Erythema nodosum and erythema multiforme also have been associated with infectious mononucleosis, but these complications are not common.
  • Petechiae may occur.
  • Jaundice may occur.
  • Severe abdominal pain is uncommon in patients with infectious mononucleosis, and it should prompt immediate attention to a possible splenic rupture.
  • In older adults, nonspecific symptoms (eg, fever, fatigue, myalgia, malaise) predominate, making it difficult to establish a specific diagnosis.
Next

Physical

  • Fever usually does not exceed 102°F in infectious mononucleosis, but it may be as high as 104°F.
  • Pharyngitis often is the most prominent physical finding.
  • Tonsillar edema and erythema with a grayish or greenish exudate are common and are clinically indistinguishable from streptococcal pharyngitis.
  • Affected lymph nodes usually are symmetrically enlarged, firm, mobile, and tender. The nodes usually do not demonstrate warmth or overlying erythema.
  • Splenomegaly is present in most cases of infectious mononucleosis, but it may not be appreciated on physical examination.
  • Hepatomegaly is found in 10-30% of cases.
  • Periorbital edema occurs in 15-35% of patients with infectious mononucleosis.
  • Petechiae of the palate, occurring at the junction of the hard and soft palate, may occur in up to one third of cases. Petechiae are not pathognomonic, but evidence of them is highly suggestive of infectious mononucleosis.
  • Jaundice may occur.
Previous
Next

Causes

Numerous etiologies exist.

  • In more than 90% of cases, infectious mononucleosis is secondary to Epstein-Barr virus (EBV) infection.
  • Other infectious causes include the following:
  • Noninfectious causes of heterophile negative infectious mononucleosis – like syndrome include medications (eg, phenytoin, sulfas) and malignancy (eg, lymphomas, leukemias).
  • Risk factors include the following:
    • Being a college or high school student
    • Kissing
    • Blood transfusion
Previous
 
 
Contributor Information and Disclosures
Author

Michael S Omori, MD  Attending Staff, Emergency Medicine Residency, St Vincent Mercy Medical Center; Acting Director, Pediatric Emergency Center, Mercy Children's Hospital; Clinical Assistant Professor, Department of Surgery, University of Toledo Medical Center, The University of Toledo College of Medicine

Michael S Omori, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert M McNamara, MD, FAAEM  Chair and Professor, Department of Emergency Medicine, Temple University School of Medicine

Robert M McNamara, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American Medical Association, Pennsylvania Medical Society, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Eric L Weiss, MD, DTM&H  Medical Director, Office of Service Continuity and Disaster Planning, Fellowship Director, Stanford University Medical Center Disaster Medicine Fellowship, Chairman, SUMC and LPCH Bioterrorism and Emergency Preparedness Task Force, Clinical Associate Progressor, Department of Surgery (Emergency Medicine), Stanford University Medical Center

Eric L Weiss, MD, DTM&H is a member of the following medical societies: American College of Emergency Physicians, American College of Occupational and Environmental Medicine, American Medical Association, American Society of Tropical Medicine and Hygiene, Physicians for Social Responsibility, Southeastern Surgical Congress, Southern Association for Oncology, Southern Clinical Neurological Society, and Wilderness Medical Society

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD  Professor of Clinical Medicine/Emergency Medicine, University of California, Los Angeles, David Geffen School of Medicine; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

References
  1. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health. Dec 2004;58(12):1032-5. [Medline].

  2. Haahr S, Plesner AM, Vestergaard BF, Hollsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand. Apr 2004;109(4):270-5. [Medline].

  3. Cunha BA, Mickail N, Laguerre M. Babesiosis mimicking Epstein Barr Virus (EBV) infectious mononucleosis: Another cause of false positive monospot tests. J Infect. May 2012;64(5):531-2. [Medline].

  4. Szoko M, Matolcsy A, Kovacs G, Simon G. Spontaneous splenic rupture as a complication of symptom-free infections mononucleosis. Orv Hetil. Jul 2007;148(29):1381-4. [Medline].

  5. Keramidas DC, Antoniou D, Marinos L. Infectious mononucleosis manifested as a cecal mass. J Pediatr Surg. Jul 2007;42(7):1295-7. [Medline].

  6. Cohen JI. Epstein-Barr virus infections, including infectious mononucleosis. In: Fauci AS, Braunwald E, Isselbacher KJ, Martin JB, eds. Harrison's Principles of Internal Medicine. 14th ed. McGraw Hill; 1998:1089-91.

  7. Cozad J. Infectious mononucleosis. Nurse Pract. Mar 1996;21(3):14-6, 23, 27-8. [Medline].

  8. Hickey SM, Strasburger VC. What every pediatrician should know about infectious mononucleosis in adolescents. Pediatr Clin North Am. Dec 1997;44(6):1541-56. [Medline].

  9. Rosen P, Ling L, Markovchick V, et al. Epstein-Barr virus (infectious mononucleosis). In: Rosen's Emergency Medicine, Concepts and Clinical Practice. 4th ed. Mosby-Year Book; 1997:2540-2541.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.